Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | v-ets avian erythroblastosis virus E26 oncogene homolog | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | fli-1 protein | Get druggable targets OG5_131947 | All targets in OG5_131947 |
Schistosoma mansoni | ets-related | Get druggable targets OG5_131947 | All targets in OG5_131947 |
Brugia malayi | Fli-1 protein | Get druggable targets OG5_131947 | All targets in OG5_131947 |
Schistosoma japonicum | ko:K09435 transcriptional regulator ERG, putative | Get druggable targets OG5_131947 | All targets in OG5_131947 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | phosphonopyruvate decarboxylase, putative | 0.0076 | 0 | 0.5 |
Mycobacterium ulcerans | acetolactate synthase 1 catalytic subunit | 0.0234 | 0.8344 | 1 |
Loa Loa (eye worm) | thiamine pyrophosphate enzyme | 0.0134 | 0.3082 | 0.2624 |
Mycobacterium ulcerans | putative oxalyl-CoA decarboxylase | 0.0234 | 0.8344 | 1 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0134 | 0.307 | 0.5 |
Trypanosoma brucei | phosphonopyruvate decarboxylase-like protein, putative | 0.0076 | 0 | 0.5 |
Mycobacterium ulcerans | acetolactate synthase | 0.0134 | 0.307 | 0.368 |
Schistosoma mansoni | acetolactate synthase | 0.02 | 0.6551 | 0.6322 |
Trypanosoma brucei | phosphonopyruvate decarboxylase-like protein, putative | 0.0076 | 0 | 0.5 |
Schistosoma mansoni | acetolactate synthase | 0.02 | 0.6551 | 0.6322 |
Loa Loa (eye worm) | fli-1 protein | 0.0265 | 1 | 1 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0087 | 0.0621 | 0.5 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0087 | 0.0621 | 0.5 |
Mycobacterium leprae | PROBABLE ACETOLACTATE SYNTHASE (LARGE SUBUNIT) ILVB (ACETOHYDROXY-ACID SYNTHASE) | 0.0234 | 0.8344 | 0.5 |
Trypanosoma cruzi | phosphonopyruvate decarboxylase, putative | 0.0076 | 0 | 0.5 |
Mycobacterium leprae | Probable Acetolactate synthase IlvG (Acetohydroxy-acid synthase)(ALS) | 0.0234 | 0.8344 | 0.5 |
Brugia malayi | Thiamine pyrophosphate enzyme, central domain containing protein | 0.0234 | 0.8344 | 0.8234 |
Mycobacterium ulcerans | hypothetical protein | 0.0234 | 0.8344 | 1 |
Leishmania major | putative pyruvate/indole-pyruvate carboxylase, putative | 0.0134 | 0.307 | 1 |
Schistosoma mansoni | ets-related | 0.0265 | 1 | 1 |
Mycobacterium tuberculosis | Probable acetolactate synthase IlvG (acetohydroxy-acid synthase)(ALS) | 0.0234 | 0.8344 | 1 |
Loa Loa (eye worm) | ILVBL protein | 0.0142 | 0.3481 | 0.3049 |
Mycobacterium ulcerans | pyruvate or indole-3-pyruvate decarboxylase Pdc | 0.0134 | 0.307 | 0.368 |
Mycobacterium tuberculosis | Probable oxalyl-CoA decarboxylase OxcA | 0.0234 | 0.8344 | 1 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0134 | 0.307 | 0.5 |
Mycobacterium ulcerans | acetolactate synthase large subunit IlvB | 0.0134 | 0.307 | 0.368 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.